<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01798316</url>
  </required_header>
  <id_info>
    <org_study_id>12-0409</org_study_id>
    <secondary_id>IRB #12-409B</secondary_id>
    <nct_id>NCT01798316</nct_id>
  </id_info>
  <brief_title>IV Acetaminophen for Postoperative Analgesia</brief_title>
  <official_title>IV Acetaminophen for Postoperative Analgesia After Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain
      management after laparoscopic cholecystectomy to determine if its use to supplement standard
      of care pain management decreases the incidence of post-operative nausea and vomiting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The recent clinical development of an intravenous (IV) acetaminophen formulation for use in
      the US has important implications for the management of postoperative pain given its safety
      profile and suitability for use in the early phase of the postoperative period. In clinical
      studies a significant opioid-sparing effect has been documented with a substantial percentage
      of patients avoiding the need for opioid rescue medication altogether. This avoidance or
      delay in the use of opioids has been shown to reduce undesirable side effects. It is proposed
      that the use of IV acetaminophen in the post anesthesia care unit (PACU) for postoperative
      analgesia after laparoscopic cholecystectomy will result in decreased incidence of post
      operative nausea and vomiting (PONV) and decreased use of narcotics.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Principal Investigator left the institution
  </why_stopped>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Postoperative Nausea and Vomiting (PONV).</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <description>Number of participants with postoperative nausea and vomiting (PONV) will be recorded during PACU stay.
PONV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Post Discharge Nausea and Vomiting (PDNV)</measure>
    <time_frame>Up to two days following surgery</time_frame>
    <description>Number of participants reporting post discharge nausea and vomiting (PDNV) documented up to 2 days following surgery.
PDNV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching following discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest Pain Intensity Score Using Numeric Rating Scale (NRS)</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <description>Highest pain intensity reported during PACU stay using a 11-point (0-10) pain intensity numeric rating scale (NRS). Higher values represent higher pain intensities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction on a 5 Point Likert Scale</measure>
    <time_frame>Up to one week following surgery</time_frame>
    <description>Number of patients very satisfied or satisfied with pain and PONV management during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity Score 1 Hour Following Surgery Using Numeric Rating Scale</measure>
    <time_frame>1 hour following surgery</time_frame>
    <description>Pain intensity score reported by participants 1 hour following surgery using an 11-point, 0-10 Numeric Rating Scale (NRS). Higher scores indicate higher pain intensities</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Patients Requiring Rescue Analgesia for Breakthrough Pain</measure>
    <time_frame>1 hour following surgery</time_frame>
    <description>Number of patients requiring rescue analgesia medication during first hour of PACU stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Narcotic Use During PACU Stay</measure>
    <time_frame>4 hours plus/minus 30 minutes</time_frame>
    <description>Narcotic medication administered during PACU stay in morphine milligram equivalents</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Nausea</condition>
  <condition>Postoperative Vomiting</condition>
  <arm_group>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV Acetaminophen administered on admission to post-anesthesia care unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care pain management regimen including opioids administered on admission to post-anesthesia care unit</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>Single dose, 1000g mg infusion over 15 minutes plus standard of care pain management regimen</description>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <other_name>Ofirmev</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Standard of care pain management regimen, no IV Acetaminophen,</description>
    <arm_group_label>Standard of care</arm_group_label>
    <other_name>As per provider: Opioids</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is undergoing pre-scheduled laparoscopic cholecystectomy;

          -  American Society of Anesthesiology patient classification status I-II

        Exclusion Criteria:

          -  Regular preoperative use of or opioids,

          -  Subjects admitted after surgery for postoperative complications other than
             postoperative pain or PONV.

          -  Subjects converted to open laparoscopic cholecystectomy

          -  Known allergy/hypersensitivity to acetaminophen

          -  Use of opioids prior to commencement of the study (&lt;7 days)

          -  Patients with chronic pain conditions or disease requiring pain control

          -  Abnormal liver function

          -  Known or suspected alcohol, drug or opiate abuse or dependence

          -  Patients with a BMI of greater than 35

          -  Other physical, mental or medical conditions that could effect participation.

          -  Abnormal renal function; serum creatinine&gt;2gm/dl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank J Overdyk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwell Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Syosset Hospital</name>
      <address>
        <city>Syosset</city>
        <state>New York</state>
        <zip>11791</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2013</study_first_posted>
  <results_first_submitted>November 18, 2016</results_first_submitted>
  <results_first_submitted_qc>May 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 31, 2017</results_first_posted>
  <last_update_submitted>May 30, 2017</last_update_submitted>
  <last_update_submitted_qc>May 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IV Acetaminophen</keyword>
  <keyword>Laparoscopic cholecystectomy</keyword>
  <keyword>Postoperative nausea</keyword>
  <keyword>Postoperative vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IV Acetaminophen</title>
          <description>IV Acetaminophen administered before PACU admission
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care</title>
          <description>Standard of care pain management regimen including opioids
Standard of Care: without IV acetaminophen</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Acetaminophen</title>
          <description>IV Acetaminophen administered before PACU admission
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care</title>
          <description>Standard of care pain management regimen including opioids
Standard of Care: No IV acetaminophen</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="53"/>
            <count group_id="B3" value="105"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.6" spread="13.0"/>
                    <measurement group_id="B2" value="44.9" spread="12.3"/>
                    <measurement group_id="B3" value="44.7" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Postoperative Nausea and Vomiting (PONV).</title>
        <description>Number of participants with postoperative nausea and vomiting (PONV) will be recorded during PACU stay.
PONV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching.</description>
        <time_frame>4 hours plus/minus 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered on admission to PACU
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV Acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Postoperative Nausea and Vomiting (PONV).</title>
          <description>Number of participants with postoperative nausea and vomiting (PONV) will be recorded during PACU stay.
PONV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Post Discharge Nausea and Vomiting (PDNV)</title>
        <description>Number of participants reporting post discharge nausea and vomiting (PDNV) documented up to 2 days following surgery.
PDNV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching following discharge.</description>
        <time_frame>Up to two days following surgery</time_frame>
        <population>Post-discharge follow up group. Patients not included in analysis were lost to follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered on admission to PACU
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Post Discharge Nausea and Vomiting (PDNV)</title>
          <description>Number of participants reporting post discharge nausea and vomiting (PDNV) documented up to 2 days following surgery.
PDNV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching following discharge.</description>
          <population>Post-discharge follow up group. Patients not included in analysis were lost to follow up.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Highest Pain Intensity Score Using Numeric Rating Scale (NRS)</title>
        <description>Highest pain intensity reported during PACU stay using a 11-point (0-10) pain intensity numeric rating scale (NRS). Higher values represent higher pain intensities.</description>
        <time_frame>4 hours plus/minus 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered before PACU admission
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Highest Pain Intensity Score Using Numeric Rating Scale (NRS)</title>
          <description>Highest pain intensity reported during PACU stay using a 11-point (0-10) pain intensity numeric rating scale (NRS). Higher values represent higher pain intensities.</description>
          <units>Units on a numerical rating scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="5" upper_limit="8"/>
                    <measurement group_id="O2" value="6" lower_limit="4" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction on a 5 Point Likert Scale</title>
        <description>Number of patients very satisfied or satisfied with pain and PONV management during hospital stay</description>
        <time_frame>Up to one week following surgery</time_frame>
        <population>Post-discharge follow up group. Patients not included in analysis were lost to follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered on admission to PACU
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV Acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction on a 5 Point Likert Scale</title>
          <description>Number of patients very satisfied or satisfied with pain and PONV management during hospital stay</description>
          <population>Post-discharge follow up group. Patients not included in analysis were lost to follow up.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Intensity Score 1 Hour Following Surgery Using Numeric Rating Scale</title>
        <description>Pain intensity score reported by participants 1 hour following surgery using an 11-point, 0-10 Numeric Rating Scale (NRS). Higher scores indicate higher pain intensities</description>
        <time_frame>1 hour following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered before PACU admission
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Intensity Score 1 Hour Following Surgery Using Numeric Rating Scale</title>
          <description>Pain intensity score reported by participants 1 hour following surgery using an 11-point, 0-10 Numeric Rating Scale (NRS). Higher scores indicate higher pain intensities</description>
          <units>Units on a numerical rating scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="3" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Patients Requiring Rescue Analgesia for Breakthrough Pain</title>
        <description>Number of patients requiring rescue analgesia medication during first hour of PACU stay</description>
        <time_frame>1 hour following surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered on admission to PACU
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV Acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Requiring Rescue Analgesia for Breakthrough Pain</title>
          <description>Number of patients requiring rescue analgesia medication during first hour of PACU stay</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Narcotic Use During PACU Stay</title>
        <description>Narcotic medication administered during PACU stay in morphine milligram equivalents</description>
        <time_frame>4 hours plus/minus 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV Acetaminophen administered on admission to PACU
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV Acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Narcotic Use During PACU Stay</title>
          <description>Narcotic medication administered during PACU stay in morphine milligram equivalents</description>
          <units>Morphine milligram equivalents</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3" lower_limit="8.5" upper_limit="18.0"/>
                    <measurement group_id="O2" value="16.8" lower_limit="10.3" upper_limit="23.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>IV Acetaminophen</title>
          <description>IV Acetaminophen administered on admission to PACU
IV Acetaminophen: Single dose, 1000g mg infusion over 15 minutes plus standard of care</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care</title>
          <description>Standard of care pain management regimen including opioids administered on admission to PACU
No IV acetaminophen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Drowziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Research, Department of Anesthesiology</name_or_title>
      <organization>Northwell</organization>
      <phone>718-470-7630</phone>
      <email>odowling@northwell.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

